Discovery and Structure–Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials

A phenotypic high-throughput screen allowed discovery of quinazolinone-2-carboxamide
derivatives as a novel antimalarial scaffold. Structure–activity
relationship studies led to identification of a potent inhibitor 19f, 95-fold more potent than the original hit compound, active
against laboratory-resistant strains of malaria. Profiling of 19f suggested a fast in vitro killing profile. In vivo activity in a murine model of human malaria in a
dose-dependent manner constitutes a concomitant benefit.